Physician profile
Deborah Holder
NPI 1326011040
$130,022.71
in general payments reported to CMS, 2019-2025
8 companies · $13K in 2025
The $13K reported for 2025 was more than what 92% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $20K · 2021: $16K · 2022: $9,322 · 2023: $31K · 2024: $18K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Consulting Fee: $4,785 · Travel and Lodging: $4,274 · Food and Beverage: $3,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,848.00 |
| Consulting Fee | $4,785.00 |
| Travel and Lodging | $4,273.99 |
| Food and Beverage | $3,396.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $123,913.49 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Immedica Pharma US, INC. | $4,785.00 | 2024 | |
| Neuropace, INC. | $934.50 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $252.52 | 2022-2024 | |
| Life Molecular Imaging Ltd | $90.58 | 2025 | Neuraceq |
| Ucb, INC. | $44.83 | 2025 | |
| Travere Therapeutics, INC. | $1.79 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Holder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.